ORIFARM A/S: Financial statements 2020
CVR: 26058708
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ORIFARM A/S (CVR 26058708) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 1,180,912,000 and a net result of DKK 6,563,000 compared with DKK 5,096,000 the year before. That is a decrease of 1.6% compared with the year before. The profit margin was 0.6%. Equity in the 2020 report amounted to DKK 42,252,000. The solvency ratio was 21.7%. The company had 42 employees in the financial year.
- Revenue
- DKK 1,180,912,000
- Gross Profit
- DKK 35,447,000
- Profit/Loss
- DKK 6,563,000
- Equity
- DKK 42,252,000
- Total Assets
- DKK 195,124,000
- Employees
- 42
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 1.2 mia. | 35.4 mio. | 6.6 mio. | 42.3 mio. | 42 |
| 2019 | 1.2 mia. | 31.4 mio. | 5.1 mio. | 35.7 mio. | 38 |
| 2018 | 1.3 mia. | 36.2 mio. | 4.3 mio. | 40.6 mio. | 45 |
| 2017 | 1.2 mia. | 34.5 mio. | 4.4 mio. | 36.3 mio. | 42 |
| 2016 | 1.2 mia. | 58 mio. | 3.6 mio. | 31.9 mio. | 72 |
Official annual report
How creditworthy is ORIFARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ORIFARM A/S has published its annual report for 2019. Revenue came to DKK 1,200,155,000, and the net result was DKK 5,096,000.
About ORIFARM A/S
ORIFARM A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JUT NR. 2181 A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM PI A/S. The company has 39 employees (2026). In 2025, the company reported revenue of DKK 1,174,659,000 and a net result of DKK 9,727,000 compared with DKK 14,865,000 the year before. Equity in the 2025 report amounted to DKK 44,048,000.